References
- Abdel-Nour M , Tsalikis J , Kleinman D , Girardin SE. (2014). The emerging role of mTOR signaling in antibacterial immunity. Immunol Cell Biol, 92, 346–353.
- Bogut A , Niedzwiadek J , Koziol-Montewka M , et al. (2014). Characterization of Staphylococcus epidermidis and Staphylococcus warnerii small-colony variants associated with prosthetic-joint infection. J Med Microbiol, 63, 176–185.
- Ivanov SS , Roy CR. (2013). Pathogen signatures activate a ubiquitination pathway that modulates the function of the metabolic checkpoint kinase mTOR. Nat Immunol, 14, 1219–1228.
- Kahl BC. (2014). Small colony variants (SCVs) of Staphylococcus aureus – A bacterial survival strategy. Infect Genet Evol, 2014, 515–522.
- Krachler AM , Woolery AR , Orth K . (2011). Manipulation of kinase signaling by bacterial pathogens. J Cell Biol, 195, 1083–1092.
- Kriegeskorte A , Koning S , Sander G , et al. (2011). Small colony variants of Staphylococcus aureus reveal distinct protein profile. Proteomics, 11, 2476–2490.
- Li P , Shi J , He Q , et al. (2015). Streptococcus pneumoniae induces autophagy through the inhibition of the PI3K-I/Akt/mTOR pathway and ROS hyperactivation in A549 cells. PLoS ONE, 10, e0122753.
- Liu XQ , Cohen JI . (2015). The role of PI3K/Akt in human herpesvirus infection: from the bench to the bedside. Virology, 479–480, 568–577.
- Magryś A , Paluch-Oleś J , Bogut A , et al. (2015). The role of programmed death ligand 1 pathway in persistent biomaterial-associated infections. J Microbiol, 5398, 544–552.
- Martin S , Saha B , Riley JL . (2012). The battle over mTOR: an emerging theatre in host-pathogen immunity. PLoS Pathog, 8, e1002894.
- Melter O , Radojevič B . (2010). Small colony variants of Staphylococcus aureus – review. Folia Microbiol, 55, 548–558.
- Monack DM , Mueller A , Falkow S . (2004). Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol, 2, 747–765.
- Oviedo-Boyso J , Cortés-Vieyra R , Huante-Mendoza A , et al. (2011). The PI3K-Akt signaling pathway is important for Staphylococcus aureus internalization by endothelial cells. Infect Immun, 79, 4569–4577.
- Proctor RA , Von Eiff C , Khal BC , et al. (2006). Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol, 4, 295–305.
- Rafii S , Roda D , Guena E , et al. (2015). Higher risk of infections with PI3K-Akt-mTOR pathway inhibitors in patients with advanced solid tumors on phase I clinical trials. Clin Cancer Res, 21, 1869–1876.
- Sendi P , Proctor RA . (2009). Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends Microbiol, 17, 54–58.
- Tattoli I , Philpott DJ , Girardin SE . (2012). The bacterial and cellular determinants controlling the recruitment of mTOR to the Salmonella-containing vacuole. Biol Open, 1,1215–1225.
- Thi EP , Lambertz U , Reiner NE . (2012). Sleeping with the enemy: how intracellular pathogens cope with a macrophage lifestyle. PLoS Pathog, 8, 1002551.
- Tuchscherr L , Heitmann V , Hussain M , et al. (2010). Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis, 202, 1031–1040.
- Xie S , Chen M , Yan B , et al. (2014). Identification of a role for the PI3K/Akt/mTOR signaling pathway in innate immune cells. PLoS One, 9, e94496.
- Zullo AJ , Smith KLJ , Lee S . (2014). Mammalian target of Rapamycin inhibition and mycobacterial survival are uncoupled in murine macrophages. BMC Biochem, 15. doi:10.1186/1471-2091-15-4.